Planned Meetings

NIDA will hold a Frontiers in Addiction Meeting in conjunction with the Society for Neuroscience Meeting, November 11, 2005 in Washington, D.C. The meeting will include sessions on: Addiction and Obesity-Brain System Commonalities; Keynote Speech: Jacob P. Waletzky Memorial Award Presentation; Neurobiological Basis for Co-Occurring Substance Abuse and Mental Illness; mGluR: A Substrate in the Neurobiology of Addiction; Reconsolidation of Memory: A New Approach to Treat Drug Addiction?; and Adolescent Drug Abuse: Brain Development, Cognition, and Vulnerability. In addition, there will be a poster session that will include young and international investigators.

Drs. Eve Reider and Elizabeth Robertson, DESPR, have planned a meeting titled Bidirectional Influences of Drug Abuse and Child Abuse and Neglect. This meeting is sponsored by NIDA's Office of Science Policy and Communication in conjunction with the Child Welfare League of America. It will be held October 27, 2005 at the Holiday Inn Select in Bethesda, Maryland.

Dr. Jag Khalsa, Dr. Jacques Normand, Director, Office on AIDS, Dr. Pat Needle, and the NIH OAR Staff will present an Indo-US Workshop on AIDS and Drug Abuse, New Delhi, India, October 27-30, 2005. NIDA/NIH supported researchers including Drs. Strathdee, Wanke, Flanigan and many others will exchange current research with the Indian counterparts, foster collaborations, and discuss ways to facilitate approval of research protocols by the respective approval authorities.

National CTN Steering Committee Meetings are planned for the following dates and locations: October 24-28, 2005, Bethesda, MD, and March 21-22, 2006, in Dallas, Texas.

A NIDA meeting entitled The NIH Roadmap: Inviting Drug Abuse and Addiction Researchers to Contribute to the Clinical Research Enterprise will be held preceding the CTN Steering Committee Meeting, October 24, 2005, in Bethesda, Maryland. The one-day symposium will provide clinical researchers with a better understanding of the NIH Roadmap and opportunities available under Re-Engineering the Clinical Research Enterprise.

The CTN Data and Safety Monitoring Board will meet November 16-18, 2005, in Bethesda, Maryland. The group will review the continuing progress of the active CTN's protocols.